News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Daily News Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa Michael O'Riordan September 16, 2016
News Industry News Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers September 15, 2016
News Daily News Alcohol and the Heart: Boozing May Boost A-fib Risk by Enlarging the Left Atrium Todd Neale September 14, 2016
News Daily News Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns Todd Neale September 12, 2016
News Daily News The Benefits of Exercise Aren’t Affected By Family History of Heart Disease Yael L. Maxwell September 08, 2016
News Daily News Los Beneficios del Ejercicio Físico No se Ven Afectados por la Historia Familiar de Cardiopatía Yael L. Maxwell September 08, 2016
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Daily News Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates Michael O'Riordan May 17, 2016
Presentation Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses Presenter: Haris Riaz May 11, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Un Nuevo Análisis del COGENT Avala el Uso de PPI en Pacientes con Dosis Bajas de Aspirina Caitlin E. Cox March 23, 2016
News Daily News New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin Caitlin E. Cox March 23, 2016
Presentation Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy Presenter: Muthia Vaduganathan March 22, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Daily News Un Ensayo Afirma que la Aspirina es Segura Antes de una Cirugía en Arterias Coronarias Todd Neale February 25, 2016